BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 10372727)

  • 1. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S; Massien C; Lahlou N; Roger M; Debuire B; Diquet B; Chatellier G; Azizi M; Faucounau V; Porchet H; Forette F; Baulieu EE
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT; Neumann O; Hellhammer DH; Geiben AC; Strasburger CJ; Dressendörfer RA; Pirke KM; Kirschbaum C
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].
    Römmler A
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):79-90. PubMed ID: 12649580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ; O'Keane V; Miell JP
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
    Jankowski CM; Gozansky WS; Kittelson JM; Van Pelt RE; Schwartz RS; Kohrt WM
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M; Rubino S; Spinetti A; Parrini D; Luisi S; Casarosa E; Petraglia F; Genazzani AR
    Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels.
    Smit P; van Schaik RH; van der Werf M; van den Beld AW; Koper JW; Lindemans J; Pols HA; Brinkmann AO; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5313-6. PubMed ID: 15985487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ; Nolan JJ; Nelson JC; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH; Härle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1990 Sep; 71(3):696-704. PubMed ID: 2144295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat tissue: a steroid reservoir and site of steroid metabolism.
    Deslypere JP; Verdonck L; Vermeulen A
    J Clin Endocrinol Metab; 1985 Sep; 61(3):564-70. PubMed ID: 3160722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.